City

Clinical trials near Minneapolis, United States

Active studies with a listed research site in Minneapolis, United States.

21active studies

10recruiting now

13countries represented

74largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowNot applicable

tDCS With Cognitive Training to Reduce Impulsivity and Weight in Veterans With Obesity

ObesityCondition

Sham Transcranial Direct Current Stimulation (tDCS), Active Transcranial Direct Current Stimulation (tDCS)Treatment

United States1 locations

VA Office of Research and DevelopmentSponsor

Updated 2026-09-08 · NCT05225233See eligibility →

Recruiting nowPhase 3

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Obesity, OverweightCondition

aleniglipron, aleniglipronTreatment

United States74 locations

Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure TherapeuticsSponsor

Updated 2026-09-01 · NCT07654374See eligibility →

Recruiting nowPhase 2

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

B-cell Acute Lymphoblastic Leukemia, ObesityCondition

IDEAL2 InterventionTreatment

United States16 locations

Etan OrgelSponsor

Updated 2026-08-19 · NCT05082519See eligibility →

Recruiting nowPhase 3

Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)

Alcohol Use DisorderCondition

Semaglutide, PlaceboTreatment

United States19 locations

VA Office of Research and DevelopmentSponsor

Updated 2026-08-12 · NCT07218354See eligibility →

Recruiting nowPhase 4

A Proof-of-Concept Study to Evaluate Topical-Lingual Semaglutide in Adults With Obesity

Obesity & OverweightCondition

Semaglutide 6 mg liquid emulsion formulation, Wegovy® (semaglutide) TabletTreatment

United States1 locations

Gila Therapeutics, Inc.Sponsor

Updated 2026-07-27 · NCT07728383See eligibility →

Recruiting nowNot applicable

Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention

Chronic Obstructive Pulmonary Disease, Obstructive Sleep ApneaCondition

FOCuSEd Integrated Intervention, Enhanced Usual CareTreatment

United States5 locations

Seattle Institute for Biomedical and Clinical ResearchSponsor

Updated 2026-07-22 · NCT06390345See eligibility →

Recruiting nowNot applicable

Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss

Peripheral Artery Disease, Overweight or ObesityCondition

Weight loss, ExerciseTreatment

United States7 locations

Northwestern UniversitySponsor

Updated 2026-05-07 · NCT04228978See eligibility →

Recruiting nowPhase 4

PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes

Type2Diabetes, ASCVDCondition

SGLT2 inhibitor, GLP-1 receptor agonistTreatment

United States36 locations

Brigham and Women's HospitalSponsor

Updated 2026-04-13 · NCT05390892See eligibility →

Recruiting nowPhase 1, Phase 2

Project SHINE (Sleep Health INitiative for Equity): Culturally Informing a Sleep Extension Intervention for African American Adults

Obesity, Insufficient SleepCondition

sleep extension intervention, contact control interventionTreatment

United States1 locations

University of MinnesotaSponsor

Updated 2025-12-17 · NCT06226077See eligibility →

Recruiting nowNot applicable

Family, Responsibility, Education, Support, and Health for Food Responsiveness

Obesity, ChildhoodCondition

Regulation of Cues, Family Based Behavioral TreatmentTreatment

United States2 locations

University of California, San DiegoSponsor

Updated 2025-05-11 · NCT06207110See eligibility →

Opening soonPhase 4

GLP-1 Plus Lifestyle for Overall Wellness: Find Your Way Forward

Obesity, ChildhoodCondition

SemaglutideTreatment

United States1 locations

University of MinnesotaSponsor

Updated 2026-06-16 · NCT06977438See eligibility →

Invitation onlyNot applicable

Family Matters Intervention

Childhood Obesity, Cardiovascular Disease PreventionCondition

In-home Visits and Food Preparation Activities, Ecological Momentary InterventionTreatment

United States2 locations

University of Colorado, DenverSponsor

Updated 2025-09-22 · NCT02669797See eligibility →

Active, not recruitingNot applicable

Maternal Obesity, Breast Milk Composition, and Infant Growth

Obesity, PregnancyCondition

Intervention not listedTreatment

United States2 locations

University of MinnesotaSponsor

Updated 2026-09-08 · NCT03301753See eligibility →

Active, not recruitingPhase 2

Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)

Overweight, Type 2 DiabetesCondition

Petrelintide, PlaceboTreatment

United States48 locations

Zealand PharmaSponsor

Updated 2026-08-21 · NCT06926842See eligibility →

Active, not recruitingNot applicable

Weight Loss Clinical Decision Support

Diabetes Mellitus, Type 2, ObesityCondition

BMI-CDSTreatment

United States1 locations

HealthPartners InstituteSponsor

Updated 2026-07-28 · NCT05198765See eligibility →

Active, not recruitingPhase 3

SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity

ObesityCondition

Liraglutide, PlaceboTreatment

Belgium, India32 locations

Novo Nordisk A/SSponsor

Updated 2026-07-09 · NCT04775082See eligibility →

Active, not recruitingPhase 3

A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

Obesity, OverweightCondition

Tirzepatide, PlaceboTreatment

Canada, Czechia33 locations

Eli Lilly and CompanySponsor

Updated 2026-06-29 · NCT06075667See eligibility →

Active, not recruitingNot applicable

Hepatic Energy Fluxes in NASH and NAS Patients

NASH - Nonalcoholic Steatohepatitis, NASCondition

Vertical Sleeve Gastrectomy (VSG)Treatment

United States1 locations

University of MinnesotaSponsor

Updated 2026-06-04 · NCT03997422See eligibility →

Active, not recruitingEarly Phase 1

Phentermine/Topiramate in Adolescents With Type 2 Diabetes and Obesity

Pediatric ObesityCondition

Phentermine/Topiramate (Qsymia), PlaceboTreatment

United States1 locations

University of MinnesotaSponsor

Updated 2026-05-22 · NCT04881799See eligibility →

Active, not recruitingPhase 2, Phase 3

SGLT2 Inhibitor Therapy in Cystic Fibrosis-related Diabetes

Cystic Fibrosis-related Diabetes, Cystic FibrosisCondition

Empagliflozin, Placebo ControlTreatment

United States1 locations

University of MinnesotaSponsor

Updated 2026-01-20 · NCT06149793See eligibility →

Active, not recruitingNot applicable

Training Effects on Fuel Metabolism

Healthy Subjects, Lean Trained SubjectsCondition

Running Program, Yoga ProgramTreatment

United States1 locations

University of MinnesotaSponsor

Updated 2026-01-08 · NCT02150889See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.

Clinical trials near Minneapolis, United States

Current studies

Related cities